We are live on ! Find out more
LWMM

Legacy Wealth Management (Mississippi) Portfolio holdings

AUM $390M
1-Year Est. Return 27.84%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+27.84%
3 Year Est. Return
+89.05%
5 Year Est. Return
+112.68%
10 Year Est. Return
–
AUM
$187M
AUM Growth
+$6.56M
Cap. Flow
+$4.82M
Cap. Flow %
2.58%
Top 10 Hldgs %
44.66%
Holding
107
New
5
Increased
17
Reduced
20
Closed
3

Top Buys

Rank Stock Value
1
CONE
CyrusOne Inc Common Stock
CONE
+$1.28M
2
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$1.18M
3
ADUS icon
Addus HomeCare
ADUS
+$1.1M
4
VST icon
Vistra
VST
+$920K
5
CTRE icon
CareTrust REIT
CTRE
+$797K

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$241K
2
CHGG icon
Chegg
CHGG
+$208K
3
ROP icon
Roper Technologies
ROP
+$207K
4
GS icon
Goldman Sachs
GS
+$152K
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$126K

Sector Composition

Rank Sector Weight
1 Technology 16.79%
2 Healthcare 14.87%
3 Financials 13.07%
4 Consumer Staples 7.13%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
101
Amgen
AMGN
$226B
$213K 0.11%
1,000
– –
XOM icon
102
ExxonMobil
XOM
$653B
$212K 0.11%
3,600
– –
XLC icon
103
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
$208K 0.11%
+2,595
New +$215K
XLF icon
104
State Street Financial Select Sector SPDR ETF
XLF
$59.4B
$202K 0.11%
+5,380
New +$201K
CHGG icon
105
Chegg
CHGG
$88.5M
– –
-2,500
Closed -$208K
ROP icon
106
Roper Technologies
ROP
$39.5B
– –
-441
Closed -$207K
VRTX icon
107
Vertex Pharmaceuticals
VRTX
$131B
– –
-1,196
Closed -$241K
1 2 3 4
5

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
SI
Schusterman Interests Tulsa, Oklahoma $391M AUM 33.81% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return

Legacy Wealth Management (Mississippi)'s Q3 2021 Portfolio in Review

As of Q3 2021, Legacy Wealth Management (Mississippi) held 107 positions worth $187M, up 3.6% from $180M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Legacy Wealth Management (Mississippi)'s Q3 2021 filing shows 5 new, 17 increased, 20 reduced and 3 closed positions. Its largest new stake was PetIQ, Inc. Class A Common Stock: 39,310 shares worth $982K. The largest sale was Vertex Pharmaceuticals, an estimated $241K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Legacy Wealth Management (Mississippi)'s largest Q3 2021 buy was PetIQ, Inc. Class A Common Stock: 39,310 shares worth $982K.
  • Legacy Wealth Management (Mississippi) added most to CyrusOne Inc Common Stock in Q3 2021, an estimated $1.28M increase.
  • Legacy Wealth Management (Mississippi)'s biggest Q3 2021 reduction was Goldman Sachs, cutting an estimated $152K.
  • Legacy Wealth Management (Mississippi) fully exited Vertex Pharmaceuticals in Q3 2021, selling an estimated $241K.
  • Legacy Wealth Management (Mississippi)'s ten largest holdings make up 45% of its $187M portfolio in Q3 2021.
  • Legacy Wealth Management (Mississippi) opened 5 new positions and closed 3 in Q3 2021.
  • Legacy Wealth Management (Mississippi)'s portfolio value rose 3.6% quarter-over-quarter to $187M.

Based on Legacy Wealth Management (Mississippi)'s 13F filing for Q3 2021, filed 12 Dec 2024.